Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-25 of 785 for your search:
Start Over
Phase IV Study of Epoetin alfa in Women With Stage I, II, or III Breast Cancer and Chemotherapy-Related Anemia. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information.
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0011004, ORTHO-PR-00-27-012, ORTHO-PR-01-27-003, NCI-G01-2002, NCT00022386
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 04-08-09-04, NCT00245518
Learning Impairments Among Survivors of Childhood Cancer
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 6 to 18
Sponsor: NCI, Other
Protocol IDs: MEMFX2, R01CA078957, U01CA081445, P30CA021765, NCT00576472
Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: Over 12
Sponsor: NCI, Other
Protocol IDs: 1001.00, FHCRC-1001.00, NCI-G01-2008, CDR0000068886, NCT00024037
Phase II/III Randomized Study of Amifostine Followed By Protracted Fractionated Radiotherapy in Patients With Inoperable, Unresectable, or Postoperatively Recurrent Rectal Adenocarcinoma (Summary Last Modified 11/2001)
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 to physiologic 74
Sponsor: NCI
Protocol IDs: UPCC-00-A-0465, NCI-T87-0232
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069401, U10CA037420, URCC U1902, URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742
Buspirone in Reducing Shortness of Breath in Patients With Cancer
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000269487, U10CA037420, URCC U1701, NCT00053846
Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) or Pilocarpine in Treating Early Dry Mouth in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-0537, CDR0000592644, NCT00656513
Management of Insomnia in Breast Cancer Patients
Phase: Phase III, Phase II
Type: Behavioral study, Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: BRS0008, K07CA132916-01A1, 25740, NCT01011218
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: BMTCTN0801, U01HL069294, U01HL069294-06, NCT01106833
Phase III Randomized Study to Evaluate Quality-of-Life Measurement Tools in Patients with Advanced Colorectal Cancer (Summary Last Modified 04/94)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-939251, NCCTG-93-92-51
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Nortriptyline to Alleviate Symptoms of CDDP-Induced Peripheral Neuropathy (Summary Last Modified 10/94)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: NCCTG-939252, NCI-P94-0057
Phase III Randomized Study of Sucralfate Suspension vs Topical Vitamin E for the Treatment of Chemotherapy-Induced Mucositis
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-1Z93, NCI-P94-0059
Talc in Treating Patients With Malignant Pleural Effusion
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000063982, U10CA031946, CLB-9334, E-C9334, NCCTG-C9334, RTOG-9511, CALGB-9334, NCT00002622
Phase III Randomized, Double-Blind, Placebo-Controlled Study of VIT-E for the Control of Hot Flushes in Menopausal Women with Prior Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-959253, NCI-P95-0065
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Glutamine to Alleviate Stomatitis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/97)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-959251, NCI-P95-0069
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 0 to 21
Sponsor: NCI, Other
Protocol IDs: 9404, U10CA030969, POG-9404, CDR0000064664, NCT01230983
Phase III Randomized, Double-Blind, Crossover Study of Coumarin vs Placebo in Women with Postmastectomy Lymphedema (Summary Last Modified 09/96)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-949255, NCI-P96-0071
Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI, Other
Protocol IDs: 9426, POG-9426, CCG-P9426, CDR0000065013, COG-9426, NCT00002827
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065093, U10CA037420, URCC-U10994, NCI-C95-0001, URCC-URRSRB-6993, NCI-P96-0073, ECOG-U1099, C95-0001, NCT00002850
Phase III Randomized, Placebo-Controlled Study of Oral Thymidine for the Prevention of Mucositis in Patients Receiving Fluorouracil-Based Chemotherapy (Summary Last Modified 06/98)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 to 90
Sponsor: NCI
Protocol IDs: CHNMC-IRB-90014, NCI-V96-1043
Start Over